The HLA A*0201–restricted hTERT540–548 peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptor

Marco A. Purbhoo(Pharmidex (United Kingdom)), Bent K. Jakobsen(Mission Therapeutics (United Kingdom)), Deborah H. Sutton(Immunocore (United Kingdom)), Bruno Laugel(Institut des Neurosciences Paris-Saclay), Alan Bennett(AXON Neuroscience (Slovakia)), Emma Gostick(University Hospital of Wales), Ruth Moysey, Giovanna Bossi(Immunocore (United Kingdom)), Brendan J. Classon, Brian Cameron(Immunocore (United Kingdom)), Nathaniel Liddy(Immunocore (United Kingdom)), Yi Li(Hohai University), David A. Price(University Hospital of Wales), Emma Baston(Immunocore (United Kingdom)), Rebecca Ashfield(Immunocore (United Kingdom)), Joanna E. Brewer, Andrew K. Sewell(Cardiff University)
Molecular Cancer Therapeutics
July 1, 2007
Cited by 49


Related Papers